A Study of the Use of Quantiferon CMV Blood Test to Find the Length of CMV Prevention in CMV Donor (+) / Recipient (-) Solid Organ Transplant Recipients

Overview

About this study

The purpose of this study is to determine if a special laboratory test performed on a blood sample collected from the organ recipient, can accurately predict the risk or likelihood of developing CMV infection after receiving an organ from a donor exposed to CMV.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Patients 18 years old or older that will receive a solid organ transplant at Mayo Clinic

  • Participants (recipients) must be negative for CMV serology prior to transplant.

  • Donor must be seropositive for CMV

  • Patients that give us consent to be enrolled in our study and to obtain a sample of blood for QuantiFERON-CMV testing, at the above mentioned points in time.

Exclusion criteria:

  • Lack of informed consent

     

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Raymund Razonable, M.D.

Closed for enrollment

Contact information:

Maria Dioverti Prono M.D.

(507)255-7763

DiovertiProno.Maria@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available